Literature DB >> 22613852

Etiology and pathogenesis of adverse drug reactions.

O Hausmann1, B Schnyder, W J Pichler.   

Abstract

In clinical routine, adverse drug reactions (ADR) are common, and they should be included in the differential diagnosis in all patients undergoing drug treatment. Only part of those ADR are immune-mediated hypersensitivity reactions and thus true drug allergies. Far more common are non-immune-mediated ADR, e.g. due to the pharmacological properties of the drug or to the individual predisposition of the patient (enzymopathies, cytokine dysbalance, mast cell hyperreactivity). In true drug allergiesT cell- and immunoglobulin E (lgE)-mediated reactions dominate the clinical presentation. T cell-mediated ADR usually have a delayed appearance and include skin eruptions in most cases. Nevertheless, it should not be forgotten that they may involve systemic T cell activation and thus take a severe, sometimes lethal turn. Clinical danger signs are involvement of mucosal surfaces, blistering within the exanthematous skin areas and systemic symptoms, e.g. fever or malaise. Drug presentation via antigen-presenting cells to T cells can either involve the classical pathway of haptenization of endogenous proteins or be directly mediated via noncovalent binding to immune receptors (MHC molecules or T cell receptors), the so-called p-i concept. Flare-up reactions during the acute phase of T cell-mediated ADR should not be mistaken for true drug allergies, as they only occur in the setting of a highly activated T cell pool. IgE-mediated ADR are less frequent and involve mast cells and/or basophils as peripheral effector cells. Recent data suggest that certain patients with drug allergy have a preexistent sensitization although they have never been exposed to the culprit drug, probably due to cross-reactivity. Thus, allergic drug reactions on first encounter are possible. In general, the extent of cross-reactivity is higher in IgE-compared to T cell-mediated ADR. Based on a specific ethnic background and only for severe T cell-mediated ADR to certain drugs, a strong HLA association has been established recently.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22613852     DOI: 10.1159/000335614

Source DB:  PubMed          Journal:  Chem Immunol Allergy        ISSN: 0079-6034


  11 in total

Review 1.  [Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): a review].

Authors:  S Ständer; D Metze; T Luger; T Schwarz
Journal:  Hautarzt       Date:  2013-08       Impact factor: 0.751

Review 2.  [Immunopathology of cutaneous drug eruptions].

Authors:  D Niebel; J Wenzel
Journal:  Pathologe       Date:  2018-11       Impact factor: 1.011

Review 3.  Drug allergies and implications for dental practice.

Authors:  Daniel E Becker
Journal:  Anesth Prog       Date:  2013

4.  Characterization of T-Cell Responses to SMX and SMX-NO in Co-Trimoxazole Hypersensitivity Patients Expressing HLA-B*13:01.

Authors:  Jirawat Pratoomwun; Paul Thomson; Kanoot Jaruthamsophon; Rawiporn Tiyasirichokchai; Pimonpan Jinda; Ticha Rerkpattanapipat; Wichittra Tassaneeyakul; Nontaya Nakkam; Pawinee Rerknimitr; Jettanong Klaewsongkram; Yuttana Srinoulprasert; Munir Pirmohamed; Dean J Naisbitt; Chonlaphat Sukasem
Journal:  Front Immunol       Date:  2021-04-29       Impact factor: 7.561

Review 5.  Multifaceted MRGPRX2: New insight into the role of mast cells in health and disease.

Authors:  Saptarshi Roy; Chalatip Chompunud Na Ayudhya; Monica Thapaliya; Vishwa Deepak; Hydar Ali
Journal:  J Allergy Clin Immunol       Date:  2021-05-04       Impact factor: 14.290

6.  Fixed drug eruptions with intraoral presentation.

Authors:  Rahul Srivastava; Manorama Bihari; Jyoti Bhuvan; Ahmed Saad
Journal:  Indian J Dent       Date:  2015 Apr-Jun

7.  Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions.

Authors:  Benjamin D McNeil; Priyanka Pundir; Sonya Meeker; Liang Han; Bradley J Undem; Marianna Kulka; Xinzhong Dong
Journal:  Nature       Date:  2014-12-17       Impact factor: 49.962

8.  Local Anesthetics, Procaine, Lidocaine, and Mepivacaine Show Vasodilatation but No Type 1 Allergy: A Double-Blind, Placebo-Controlled Study.

Authors:  Stefan Weinschenk; Caroline Mergenthaler; Christina Armstrong; Richard Göllner; Markus W Hollmann; Thomas Strowitzki
Journal:  Biomed Res Int       Date:  2017-12-11       Impact factor: 3.411

Review 9.  Normative Application of Xiyanping Injection: A Systematic Review of Adverse Case Reports.

Authors:  Shiqi Chen; Joey S W Kwong; Rui Zheng; Yanping Wang; Hongcai Shang
Journal:  Evid Based Complement Alternat Med       Date:  2018-11-15       Impact factor: 2.629

10.  Epidemiology of Severe Cutaneous Adverse Drug Reaction and Its HLA Association among Pediatrics.

Authors:  Hossein Esmaeilzadeh; Shirin Farjadian; Soheila Alyasin; Hamid Nemati; Hesamodin Nabavizadeh; Elmira Esmaeilzadeh
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.